Is Seres Therapeutics Inc (NASDAQ: MCRB) Back In The Buying Zone?
Fidelity Management & Research Co recently announced the acquisition of new stake in Seres Therapeutics Inc (NASDAQ:MCRB). The institutional investor has increased its shareholding in the Healthcare company by 0.24% to 19.23 million shares with purchase of 45484.0 shares. This fresh investment now brings its stake to 15.00% valued currently at $29.42 million. In addition, […]
